LEXXW vs MA · rev $705.9K vs P/E 38, rev $17.68B
Lexaria Bioscience Corp (LEXXW) versus Mastercard Inc (MA) — a side-by-side from cached financials, not a winner call.
Lexaria Bioscience Corp (LEXXW) common stock listed on US.
Mastercard Inc (MA) is a credit services company listed on US. It is led by Michael Miebach.
Latest reported LEXXW revenue for 2025-08-31 was $705.9K. Net income was -$11.9M. Revenue was up 52.0% from 2024-08-31 to 2025-08-31. LEXXW currently screens at market cap $33.8M.
Latest reported MA revenue for 2026-06-30 was $17.68B. Net income was $8.27B. MA currently screens at market cap $515.12B and trailing P/E 38.4.
LEXXW currently screens at market cap $33.8M. MA currently screens at market cap $515.12B and trailing P/E 38.4.
Not investment advice. Open the LEXXW and MA stock pages for the full models.
Not investment advice.